Sat, Oct 19 12:54am


FGEN $38.80 1.71 (4.22%)
FibroGen Inc
NASDAQ: FGEN $4 Billion Mid-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 76%. 1 Year Return 27%. 2019 YTD Return 15%. Earnings in 26 days on Thu, Nov 14. (Use the Earnings tab below to add this date to your calendar.)

FGEN Profile

Market Cap 4 Billion
FGEN Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Visit Website

FGEN Earnings

EPS 1.34 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Thu, Nov 14, 2019 (In 26 days)

FGEN Dividend

Yield --
Ex-Date --
Pay Date --
History --

FGEN Charts

1 Year
May 10, 2019
Feb 28, 2019


Symbol Price Day Ξ” YTD Ξ”
FGEN $38.80 -4.22% -15.32%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy